サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1261067

妊娠検査キット：世界の展望・予測 (2023-2028年)

Pregnancy Test Kits Market - Global Outlook & Forecast 2023-2028
出版日: | 発行: Arizton Advisory & Intelligence | ページ情報: 英文 | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
妊娠検査キット：世界の展望・予測 (2023-2028年)
出版日: 2023年04月20日
発行: Arizton Advisory & Intelligence
ページ情報: 英文
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の妊娠検査キットの市場規模は、2022年から2028年にかけて5.08%のCAGRで成長すると予測されています。

デジタル妊娠検査キットの台頭、妊娠状態の早期発見のための妊娠検査キットの進歩、計画外妊娠の割合の増加、母体年齢の高い年齢層における出生率の上昇などの要因が同市場の成長を推進しています。

当レポートでは、世界の妊娠検査キットの市場を調査し、市場の定義と概要、市場機会・市場動向、市場影響因子の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 調査目的

第3章 調査プロセス

第4章 調査対象・調査範囲

第5章 レポートの前提・注記

第6章 市場概要

第7章 重要考察

第8章 イントロダクション

第9章 市場機会・市場動向

  • デジタル妊娠検査キットの台頭
  • 妊娠の早期発見のための妊娠検査キットの進歩
  • 次世代の妊娠検査キットに向けた進歩と製品の発売

第10章 市場成長の実現因子

  • 望まない妊娠率の上昇
  • 中所得地域における妊娠検査キットの認知度と採用の高まり
  • 母性年齢の高い出生率の上昇

第11章 市場抑制要因

  • 低所得国における妊娠検査キットへの認識とアクセスの欠如
  • 検査の精度に関する懸念
  • 避妊薬の使用の増加

第12章 市場情勢

  • 市場概要
  • 市場規模・予測
    • 検体タイプ別の洞察
    • 製品別の洞察
    • 流通チャネル別の洞察
    • 地域別の洞察
  • ファイブフォース分析

第13章 検体タイプ

  • 市場スナップショット・成長エンジン
  • 市場概要
  • 尿
  • その他

第14章 製品

  • 市場スナップショット・成長エンジン
  • 市場概要
  • ライン
  • デジタル

第15章 流通経路

  • 市場スナップショット・成長エンジン
  • 市場概要
  • オフライン
  • オンライン

第16章 地域

  • 市場スナップショット・成長エンジン
  • 地理的概要

第17章 北米

第18章 アジア太平洋

第19章 欧州

第20章 ラテンアメリカ

第21章 中東・アフリカ

第22章 競合情勢

  • 競合概要
  • 市場シェア分析

第23章 主要企業プロファイル

  • ABBOTT
  • CHURCH & DWIGHT
  • SPD SWISS PRECISION DIAGNOSTICS GMBH

第24章 その他の有力ベンダー

  • ACCUBIOTECH
  • AXIS MEDICARE
  • ADVACARE PHARMA
  • BIOSYNEX
  • BIOMERIEUX
  • CARDINAL HEALTH
  • CUPID LIMITED
  • CONFIRM BIOSCIENCES
  • CYCLOTEST.DE
  • EVERLY HEALTH (NATALIST)
  • FAIRHAVEN HEALTH
  • FEMOMETER
  • GERATHERM MEDICAL AG
  • GERMAINE LABORATORIES
  • INTEC
  • JOHNSON & JOHNSON
  • MANKIND PHARMA
  • MERIL LIFE SCIENCES
  • MP BIOMEDICALS
  • MEDSOURCE OZONE BIOMEDICALS
  • HEALTHPOINT (CLEAR&SIMPLE)
  • PRINCETON BIOMEDITECH CORPORATION
  • PIRAMAL ENTERPRISES LTD
  • QUIDELORTHO
  • RO
  • SALIGNOSTICS
  • SIEMENS HEALTHINEERS
  • SUGENTECH
  • TURKLAB A.S.
  • TRINITY BIOTECH
  • WONDFO

第25章 レポートサマリー

  • 重要ポイント
  • 戦略的提言

第26章 定量的サマリー

第27章 付録

目次
Product Code: ARZ230309

The global pregnancy test kits market is expected to grow at a CAGR of 5.08% during 2022 to 2028

MARKET TRENDS & DRIVERS

Product Launched & Progress Towards the Next-generation Pregnancy Test Kits

With the rising research and development and advancement in pregnancy testing kits, vendors offer innovative kits that fulfill consumers' demands. New product launched in the pregnancy test kits market offers lucrative growth opportunities. In pregnancy test kit industries, manufacturers focus on pregnancy rapid tests with advanced technologies that are more sensitive and effective to improve the experience of consumers. In recent years, vendors have launched some digital and saliva-based pregnancy test kits.

The Emergence of Digital Pregnancy Testing Kits

In recent years, the introduction of digital pregnancy test kits, the new era in pregnancy test kits, has rapidly increased the adoption and offered market growth opportunities. The devices like Clearblue Easy have quickly been adopted as home digital pregnancy test kits. In addition, some other companies- leading industry players- started developing digital pregnancy test kits. The constant advancement in pregnancy test kits and their technology is expected to boost the industry's growth over the forecast period.

Advancement in Pregnancy Testing Kits for Early Detection of Pregnancy Status

Most new kits come up with advancements in the global pregnancy test kits market. The test kits offer early detection (up to 5 to 6 days before missed period). These pregnancy test kits becoming more popular in recent times. The vendors offering some of the products that offer early pregnancy detection have a high potential to accelerate industry growth in the upcoming time. The demand for these test kits is increasing because people know their pregnancy status without waiting to miss their period. Most women who conceived without protected sex are the major targeted population for this kind of pregnancy test kit.

Rising Rate of Unplanned Pregnancies

Globally, approximately half of the pregnancies are unintended every year. With the increasing burden of unplanned pregnancies and rising abortion among girls and maternal women, several governments focused on increasing knowledge about pregnancy testing as a preventive measure. Among those initiatives, pregnancy testing kits were one of the leading parts. According to the World Family Planning 2022 published report (2022), around 41 countries where around half of the women who want to avoid pregnancies use modern contraceptives, while approximately 22 countries are only from Sub-Saharan Africa. The population that avoids pregnancies promotes the growth of the pregnancy test kits market. With increasing knowledge among adult, teenage, and maternal-age women about unintended pregnancy, the demand for pregnancy test kits increases to avoid unwanted pregnancies and family planning.

Rising Birth Rate in Advanced Maternal Age

Pregnancy at the advanced maternal age (age 35 and above) is recognized as a risk factor for adverse maternal and perinatal outcomes. However, advanced maternal-age pregnancies have become more popular over the last two decades. The possible maternal risk and pregnancy complications at age 35 and above include chromosomal abnormalities, spontaneous Miscarriage, preterm labor, gestational diabetes mellitus, pre-eclampsia, cesarean delivery, and stillbirth. Some complications are commonly known among educated women in developed countries. These factors turn most women to test their pregnancy status as a preventive method at home, contributing to the home pregnancy test kits market.

SEGMENTATION INSIGHTS

INSIGHTS BY SAMPLE TYPE

The global pregnancy test kits market by sample type is segmented into urine and other samples. The urine sample segment accounted for a higher global pregnancy test kit market share in 2022. A urine sample is considered an ideal sample for pregnancy testing. Women or medical professionals commonly choose the urine sample in clinical or home pregnancy testing. The capacity of a urine sample to carry a high volume of hCG hormone is a vital biomarker of pregnancy that accelerates segmental growth. A self-test is expected to be positive in at-home pregnancy when hCG is obtained in urine. A urine-based test at home generally requires a higher hCG level to turn out the result. The factors that increase the demand for urine sample-based pregnancy test kits are easy to collect and handle and convenient methods at home.

Segmentation by Sample Type

  • Urine
  • Others

INSIGHTS BY PRODUCT TYPE

The line product segment dominated the global pregnancy test kits market in 2022. Line indicator pregnancy test kit types are affordable and commonly available as an OTC product. Due to the no-prescription requirement, the consumption rate of line indicators as pregnancy test kits is comparatively higher than the digital and strip type. Furthermore, the consumption rate is increased with the increasing access to this type of pregnancy test kits through e-commerce platforms at a very affordable price.

Segmentation by Product

  • Line
  • Digital

INSIGHTS BY DISTRIBUTION CHANNELS

The global pregnancy test kits market by distribution channel is segmented offline and online. The offline segment included pharmacies, medical shops, pharmaceutical retailers, medical centers, and supermarkets, which drive the higher sale of pregnancy test kits and accelerate the growth. In recent years, the momentum of country-level regulatory approvals and targeted distribution of pregnancy tests have been the major steps to increase access to pregnancy test kits in pharmacies. In 2022, the offline distribution channels segment accounted for a higher industry share in the global pregnancy test kits market. Further, online channels offer easy access and a convenient way to buy pregnancy test kits.

Segmentation by Distribution Channels

  • Offline
  • Online

GEOGRAPHICAL ANALYSIS

North America dominated the global pregnancy test kits market in 2022, accounting for a nearly 33% share. The high awareness and acceptance of pregnancy testing kits among the teenage population, the rising expenditure on reproductive healthcare services and solutions by the adult and advanced maternal-age women population, and the increasing burden of unintended pregnancies in the region fuel the market growth.

Segmentation by Geography

  • North America
    • US
    • Canada
  • APAC
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • South Africa
    • Saudi Arabia

VENDOR LANDSCAPE

The global pregnancy test kits market is highly competitive and has many global, regional, and domestic players offering a comprehensive product portfolio of pregnancy test kits. Some global industry players have acquired high market penetration with a broader distribution network and business strategies. Moreover, some companies collaborate with healthcare settings and government authorities to increase the sale of pregnancy test kits. The competitive landscape varies from country to country. In North America, the competition for pregnancy test kits is high due to consumer expenditure, stronger offline and online distribution channels, and a high adoption rate of pregnancy test kits.

Key Company Profiles

  • Abbott
  • Church & Dwight
  • SPD Swiss Precision Diagnostics GmbH

Other Prominent Vendors

  • AccuBioTech
  • Axis Medicare
  • AdvaCare Pharma
  • Biosynex
  • bioMerieux
  • Cardinal Health
  • Cupid Limited
  • Confirm BioSciences
  • Cyclotes.de
  • Everly Health (Natalist)
  • Fairhaven Health
  • Femometer
  • Geratherm Medical AG
  • Germaine Laboratories
  • INTEC
  • Johnson & Johnson
  • Mankind Pharma
  • Meril Life Sciences
  • MP Biomedicals
  • Medsource Ozone Biomedicals
  • Healthpoint
  • Princeton BioMeditech Corporation
  • Piramal Enterprises Ltd (Piramal Pharma)
  • QuidelOrtho
  • Ro
  • Salignostics
  • Siemens Healthineers
  • SUGENTECH
  • Turklab A.S.
  • Trinity Biotech
  • Wondfo

KEY QUESTIONS ANSWERED:

  • 1. How big is the pregnancy test kits market?
  • 2. What is the growth rate of the pregnancy test kits market?
  • 3. Who are the key players in the global pregnancy test kits market?
  • 4. What are the growing trends in the pregnancy test kits market?
  • 5. Which region holds the most significant global pregnancy test kits market share?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 PREMIUM INSIGHTS

  • 7.1 OVERVIEW

8 INTRODUCTION

  • 8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 EMERGENCE OF DIGITAL PREGNANCY TESTING KITS
  • 9.2 ADVANCES IN PREGNANCY TESTING KITS FOR EARLY DETECTION OF PREGNANCY STATUS
  • 9.3 PRODUCTS LAUNCHED & PROGRESS TOWARD NEXT-GENERATION PREGNANCY TEST KITS

10 MARKET GROWTH ENABLERS

  • 10.1 THE RISING RATE OF UNINTENDED PREGNANCIES
  • 10.2 GROWING AWARENESS & ADOPTION OF PREGNANCY TEST KITS IN MIDDLE-INCOME GEOGRAPHIES
  • 10.3 RISING BIRTH RATE IN ADVANCED MATERNAL AGE

11 MARKET RESTRAINTS

  • 11.1 LACK OF AWARENESS & ACCESS TO PREGNANCY TESTING KITS IN LOW-INCOME COUNTRIES
  • 11.2 CONCERN ABOUT TESTS ACCURACY
  • 11.3 INCREASING USE OF CONTRACEPTIVES

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
    • 12.2.1 SAMPLE TYPE INSIGHTS
    • 12.2.2 PRODUCT INSIGHTS
    • 12.2.3 DISTRIBUTION CHANNELS INSIGHTS
    • 12.2.4 GEOGRAPHY INSIGHTS
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 COMPETITIVE RIVALRY

13 SAMPLE TYPE

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 URINE
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 OTHERS
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MARKET BY GEOGRAPHY

14 PRODUCT

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 LINE
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 DIGITAL
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 MARKET BY GEOGRAPHY

15 DISTRIBUTION CHANNEL

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 OFFLINE
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
    • 15.3.3 MARKET BY GEOGRAPHY
  • 15.4 ONLINE
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
    • 15.4.3 MARKET BY GEOGRAPHY

16 GEOGRAPHY

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 GEOGRAPHIC OVERVIEW

17 NORTH AMERICA

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
  • 17.3 SAMPLE TYPE
    • 17.3.1 MARKET SIZE & FORECAST
  • 17.4 PRODUCT
    • 17.4.1 MARKET SIZE & FORECAST
  • 17.5 DISTRIBUTION CHANNELS
    • 17.5.1 MARKET SIZE & FORECAST
  • 17.6 KEY COUNTRIES
    • 17.6.1 US: MARKET SIZE & FORECAST
    • 17.6.2 CANADA: MARKET SIZE & FORECAST

18 APAC

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
  • 18.3 SAMPLE TYPE
    • 18.3.1 MARKET SIZE & FORECAST
  • 18.4 PRODUCT
    • 18.4.1 MARKET SIZE & FORECAST
  • 18.5 DISTRIBUTION CHANNELS
    • 18.5.1 MARKET SIZE & FORECAST
  • 18.6 KEY COUNTRIES
    • 18.6.1 CHINA: MARKET SIZE & FORECAST
    • 18.6.2 INDIA: MARKET SIZE & FORECAST
    • 18.6.3 JAPAN: MARKET SIZE & FORECAST
    • 18.6.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 18.6.5 AUSTRALIA: MARKET SIZE & FORECAST

19 EUROPE

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
  • 19.3 SAMPLE TYPE
    • 19.3.1 MARKET SIZE & FORECAST
  • 19.4 PRODUCT
    • 19.4.1 MARKET SIZE & FORECAST
  • 19.5 DISTRIBUTION CHANNELS
    • 19.5.1 MARKET SIZE & FORECAST
  • 19.6 KEY COUNTRIES
    • 19.6.1 GERMANY: MARKET SIZE & FORECAST
    • 19.6.2 FRANCE: MARKET SIZE & FORECAST
    • 19.6.3 UK: MARKET SIZE & FORECAST
    • 19.6.4 ITALY: MARKET SIZE & FORECAST
    • 19.6.5 SPAIN: MARKET SIZE & FORECAST

20 LATIN AMERICA

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
  • 20.3 SAMPLE TYPE
    • 20.3.1 MARKET SIZE & FORECAST
  • 20.4 PRODUCT
    • 20.4.1 MARKET SIZE & FORECAST
  • 20.5 DISTRIBUTION CHANNELS
    • 20.5.1 MARKET SIZE & FORECAST
  • 20.6 KEY COUNTRIES
    • 20.6.1 BRAZIL: MARKET SIZE & FORECAST
    • 20.6.2 MEXICO: MARKET SIZE & FORECAST
    • 20.6.3 ARGENTINA: MARKET SIZE & FORECAST

21 MIDDLE EAST & AFRICA

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
  • 21.3 SAMPLE TYPE
    • 21.3.1 MARKET SIZE & FORECAST
  • 21.4 PRODUCT
    • 21.4.1 MARKET SIZE & FORECAST
  • 21.5 DISTRIBUTION CHANNELS
    • 21.5.1 MARKET SIZE & FORECAST
  • 21.6 KEY COUNTRIES
    • 21.6.1 TURKEY: MARKET SIZE & FORECAST
    • 21.6.2 SOUTH AFRICA: MARKET SIZE & FORECAST
    • 21.6.3 SAUDI ARABIA: MARKET SIZE & FORECAST

22 COMPETITIVE LANDSCAPE

  • 22.1 COMPETITION OVERVIEW
  • 22.2 MARKET SHARE ANALYSIS
    • 22.2.1 ABBOTT
    • 22.2.2 CHURCH & DWIGHT
    • 22.2.3 SPD SWISS PRECISION DIAGNOSTICS

23 KEY COMPANY PROFILES

  • 23.1 ABBOTT
    • 23.1.1 BUSINESS OVERVIEW
    • 23.1.2 PRODUCT OFFERINGS
    • 23.1.3 KEY STRATEGIES
    • 23.1.4 KEY STRENGTHS
    • 23.1.5 KEY OPPORTUNITIES
  • 23.2 CHURCH & DWIGHT
    • 23.2.1 BUSINESS OVERVIEW
    • 23.2.2 PRODUCT OFFERINGS
    • 23.2.3 KEY STRATEGIES
    • 23.2.4 KEY STRENGTHS
    • 23.2.5 KEY OPPORTUNITIES
  • 23.3 SPD SWISS PRECISION DIAGNOSTICS GMBH
    • 23.3.1 BUSINESS OVERVIEW
    • 23.3.2 PRODUCT OFFERINGS
    • 23.3.3 KEY STRATEGIES
    • 23.3.4 KEY STRENGTHS
    • 23.3.5 KEY OPPORTUNITIES

24 OTHER PROMINENT VENDORS

  • 24.1 ACCUBIOTECH
    • 24.1.1 BUSINESS OVERVIEW
    • 24.1.2 PRODUCT OFFERINGS
  • 24.2 AXIS MEDICARE
    • 24.2.1 BUSINESS OVERVIEW
    • 24.2.2 PRODUCT OFFERINGS
  • 24.3 ADVACARE PHARMA
    • 24.3.1 BUSINESS OVERVIEW
    • 24.3.2 PRODUCT OFFERINGS
  • 24.4 BIOSYNEX
    • 24.4.1 BUSINESS OVERVIEW
    • 24.4.2 PRODUCT OFFERINGS
  • 24.5 BIOMERIEUX
    • 24.5.1 BUSINESS OVERVIEW
    • 24.5.2 PRODUCT OFFERINGS
  • 24.6 CARDINAL HEALTH
    • 24.6.1 BUSINESS OVERVIEW
    • 24.6.2 PRODUCT OFFERINGS
  • 24.7 CUPID LIMITED
    • 24.7.1 BUSINESS OVERVIEW
    • 24.7.2 PRODUCT OFFERINGS
  • 24.8 CONFIRM BIOSCIENCES
    • 24.8.1 BUSINESS OVERVIEW
    • 24.8.2 PRODUCT OFFERINGS
  • 24.9 CYCLOTEST.DE
    • 24.9.1 BUSINESS OVERVIEW
    • 24.9.2 PRODUCT OFFERINGS
  • 24.10 EVERLY HEALTH (NATALIST)
    • 24.10.1 BUSINESS OVERVIEW
    • 24.10.2 PRODUCT OFFERINGS
  • 24.11 FAIRHAVEN HEALTH
    • 24.11.1 BUSINESS OVERVIEW
    • 24.11.2 PRODUCT OFFERINGS
  • 24.12 FEMOMETER
    • 24.12.1 BUSINESS OVERVIEW
    • 24.12.2 PRODUCT OFFERINGS
  • 24.13 GERATHERM MEDICAL AG
    • 24.13.1 BUSINESS OVERVIEW
    • 24.13.2 PRODUCT OFFERINGS
  • 24.14 GERMAINE LABORATORIES
    • 24.14.1 BUSINESS OVERVIEW
    • 24.14.2 PRODUCT OFFERINGS
  • 24.15 INTEC
    • 24.15.1 BUSINESS OVERVIEW
    • 24.15.2 PRODUCT OFFERINGS
  • 24.16 JOHNSON & JOHNSON
    • 24.16.1 BUSINESS OVERVIEW
    • 24.16.2 PRODUCT OFFERINGS
  • 24.17 MANKIND PHARMA
    • 24.17.1 BUSINESS OVERVIEW
    • 24.17.2 PRODUCT OFFERINGS
  • 24.18 MERIL LIFE SCIENCES
    • 24.18.1 BUSINESS OVERVIEW
    • 24.18.2 PRODUCT OFFERINGS
  • 24.19 MP BIOMEDICALS
    • 24.19.1 BUSINESS OVERVIEW
    • 24.19.2 PRODUCT OFFERINGS
  • 24.20 MEDSOURCE OZONE BIOMEDICALS
    • 24.20.1 BUSINESS OVERVIEW
    • 24.20.2 PRODUCT OFFERINGS
  • 24.21 HEALTHPOINT (CLEAR&SIMPLE)
    • 24.21.1 BUSINESS OVERVIEW
    • 24.21.2 PRODUCT OFFERINGS
  • 24.22 PRINCETON BIOMEDITECH CORPORATION
    • 24.22.1 BUSINESS OVERVIEW
    • 24.22.2 PRODUCT OFFERINGS
  • 24.23 PIRAMAL ENTERPRISES LTD
    • 24.23.1 BUSINESS OVERVIEW
    • 24.23.2 PRODUCT OFFERINGS
  • 24.24 QUIDELORTHO
    • 24.24.1 BUSINESS OVERVIEW
    • 24.24.2 PRODUCT OFFERINGS
  • 24.25 RO
    • 24.25.1 BUSINESS OVERVIEW
    • 24.25.2 PRODUCT OFFERINGS
  • 24.26 SALIGNOSTICS
    • 24.26.1 BUSINESS OVERVIEW
    • 24.26.2 PRODUCT OFFERINGS
  • 24.27 SIEMENS HEALTHINEERS
    • 24.27.1 BUSINESS OVERVIEW
    • 24.27.2 PRODUCT OFFERINGS
  • 24.28 SUGENTECH
    • 24.28.1 BUSINESS OVERVIEW
    • 24.28.2 PRODUCT OFFERINGS
  • 24.29 TURKLAB A.S.
    • 24.29.1 BUSINESS OVERVIEW
    • 24.29.2 PRODUCT OFFERINGS
  • 24.30 TRINITY BIOTECH
    • 24.30.1 BUSINESS OVERVIEW
    • 24.30.2 PRODUCT OFFERINGS
  • 24.31 WONDFO
    • 24.31.1 BUSINESS OVERVIEW
    • 24.31.2 PRODUCT OFFERINGS

25 REPORT SUMMARY

  • 25.1 KEY TAKEAWAYS
  • 25.2 STRATEGIC RECOMMENDATIONS

26 QUANTITATIVE SUMMARY

  • 26.1 MARKET BY GEOGRAPHY
  • 26.2 MARKET BY SAMPLE
  • 26.3 MARKET BY PRODUCT
  • 26.4 MARKET BY DISTRIBUTION CHANNELS
  • 26.5 SAMPLE TYPE: MARKET BY GEOGRAPHY
    • 26.5.1 URINE SAMPLE: MARKET BY GEOGRAPHY
    • 26.5.2 OTHER SAMPLE: MARKET BY GEOGRAPHY
  • 26.6 PRODUCT: MARKET BY GEOGRAPHY
    • 26.6.1 LINE PRODUCT: MARKET BY GEOGRAPHY
    • 26.6.2 DIGITAL: MARKET BY GEOGRAPHY
  • 26.7 DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY
    • 26.7.1 OFFLINE DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY
    • 26.7.2 ONLINE DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY

27 APPENDIX

  • 27.1 ABBREVIATIONS